The changing role of liver biopsy in diagnosis and management of haemochromatosis

Pathology

Volumn 43, Issue 5, 2011, Pages 433-439

  Bassett, Mark L ^a,b   Hickman, Peter E ^a,b   Dahlstrom, Jane E ^a,b  

^a The Australian National University   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

Biochemistry; Biopsy; Haemochromatosis; Histology; Iron; Liver

Indexed keywords

EID: 80052109985     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283490e04     Document Type: Review

References (37)

1. Pietrangelo A. Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139: 393-408.
2. Ramm GA, Ruddell RG. Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: The role of inflammation in a noninflammatory liver disease. Semin Liver Dis 2010; 30: 271-87.
3. Prati D, Maggioni M, Milani S, et al. Cooperative GroupClinical and histological characterization of liver disease in patients with transfusiondependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004; 89: 1179-86.
4. Darshan D, Frazer DM, Anderson GJ. Molecular basis of iron-loading disorders. Expert Rev Mol Med 2010; 12: E36.
5. Deugnier Y. The iron driven pathway of hepcidin synthesis. Gastroenterol Clin Biol 2010; 34: 351-4.
6. Mortimore M, Merryweather-Clarke AT, Robson KJ, et al. The haemochromatosis gene: A global perspective and implications for the Asia-Pacific region. J Gastroenterol Hepatol 1999; 14: 838-43.
7. Tsui WM, Lam PW, Lee KC, et al. The C282Y mutation of the HFE gene is not found in Chinese haemochromatotic patients: Multicentre retrospective study. Hong Kong Med J 2000; 6: 153-8.
8. Royal College of Pathologists of Australasia. RCPA Manual. Sydney: RCPA, 2009. http://www.rcpamanual.edu.au; accessed 16 April 2011.
9. Halliday JW, Searle J. Hepatic iron deposition in human disease and animal models. Biometals 1996; 9: 205-9.
10. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 2007; 13: 4755-60.
11. Searle J, Leggett BA, Crawford DHG, Powell LW. MacSween's Pathology of the Liver. 4th ed. China: Churchill Livingstone, 2002; 259-270.
12. Brunt EM, Olynk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: Relationship to HFE mutations. Am J Gastroenterol 2000; 95: 1788-93.
13. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.
14. Allen KJ, Gurrin LC, Constantine CC, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med 2008; 358: 221-30.
15. Walsh A, Dixon JL, Ramm GA, et al. The clinical relevance of compound heterozygosity for the C282Yand H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol 2006; 4: 1403-10.
16. Gurrin LC, Bertalli NA, Dalton GW, et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology 2009; 50: 94-101.
17. Cheng R, Barton JC, Morrison ED, et al. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. J Clin Gastroenterol 2009; 43: 569-73.
18. MacSween RNM, Burt AD, Portman BC, et al. Pathology of the Liver. 4th ed China: Churchill Livingstone; 2002; 263-70.
19. Price L, Kowdley KV. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol 2009; 23: 822-8.
20. Walker RJ, Miller JP, Dymock IW, et al. Relationship of hepatic iron concentration to histochemical grading and to total chelatable body iron in conditions associated with iron overload. Gut 1971; 12: 1011-4.
21. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990; 12: 20-5.
22. Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am 2010; 18: 359-81.
23. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976; 17: 332-4.
24. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
25. Gurrin LC, Osborne NJ, Constantine CC, et al. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008; 135: 1945-52.
26. Pedersen P, Milman N. Genetic screening for HFE hemochromatosis in 6,020 Danish men: Penetrance of C282Y, H63D, and S65C variants. Ann Hematol 2009; 88: 775-84.
27. Walsh A, Dixon JL, Ramm GA, et al. The clinical relevance of compound heterozygosity for the C282Yand H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol 2006; 4: 1403-10.
28. Gurrin LC, Bertalli NA, Dalton GW, et al. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology 2009; 50: 94-101.
29. Gochee PA, Powell LW, Cullen DJ, et al. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122: 646-51.
30. Fraquelli M, Cassinerio E, Roghi A, et al. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 2010; 85: 564-8.
31. Di Marco V, Bronte F, Cabibi D, et al. Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Br J Haematol 2010; 148: 476-9.
32. Crawford DH, Murphy TL, Ramm LE, et al. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis. Hepatology 2009; 49: 418-25.
33. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359: 211-8.
34. Qian MY, Yuwei JR, Angus P, et al. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. J Gastroenterol Hepatol 2010; 25: 951-6.
35. Theise ND, Schwartz M, Miller C, et al. Macroregenerative nodules and hepatocellular carcinoma in 44 sequential adult explants with cirrhosis. Hepatology 1992; 16: 949-55.
36. Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: Role of biopsy. Liver Transpl 2007; 13 (Suppl 2): S17-23.
37. Bassett ML. HFE genotyping: Maximising the value for hemochromatosis patients and their families. J Gastroenterol Hepatol 2010; 25: 1186-8.